Charlevoix Area Hospital | |
14700 Lakeshore Drive, Charlevoix, Michigan 49720 | |
(231) 547-4024 | |
Name | Charlevoix Area Hospital |
---|---|
Type | Critical Access Hospital |
Location | 14700 Lakeshore Drive, Charlevoix, Michigan |
Ownership | Voluntary non-profit - Other |
Emergency Services | Yes |
Medicare ID (CCN) | 231322 |
NPI Number | 1346260692 |
Organization Name | MUNSON HEALTHCARE CHARLEVOIX HOSPITAL |
Address | 14700 Lake Shore Drive, Charlevoix, MI 49720 |
Hospital Type | General Acute Care Hospital - Critical Access |
Phone Number | 231-547-4024 |
News Archive
After menopause, women's levels of estrogen and progesterone fall. Their formerly lower risk for heart disease equals, even surpasses, men's risk. One possible contributing explanation for the change in risk is that sex hormones affect the sympathetic nervous system, which controls constriction of blood vessels and participates in the fight or flight response.
Pharmacyclics, Inc. announced today that the enrollment target of 350 patients for its Phase III study using ibrutinib monotherapy versus ofatumumab in patients with relapsed or refractory chronic lymphocytic leukemia / small lymphocytic lymphoma, (RESONATE) was achieved on April 3, 2013.
"India is falling behind other countries in meeting international commitments to improve obstetric care because it does not adequately monitor deaths and injuries in the critical period following childbirth and fix gaps in its health system and programmes," Human Rights Watch said Wednesday, the Hindu reports.
Learning from one's mistakes may be better than practicing to perfection, according to a new study appearing in the October 19 issue of The Journal of Neuroscience.
EyeTechCare SA, which develops non-invasive therapeutic medical devices for the ophthalmology market based on the use of ultrasound, today announces that its EyeOP1 device is to be installed in a number of hospitals in France, namely Lille University Hospital, Grenoble University Hospital and the Quinze-Vingts and Saint-Joseph hospitals in Paris. The first use of this device for the routine treatment of glaucoma patients is slated from July onwards.
› Verified 7 days ago
Able to receive lab results electronically | Not Available |
Able to track patients' lab results, tests, and referrals electronically between visits | Not Available |
News Archive
After menopause, women's levels of estrogen and progesterone fall. Their formerly lower risk for heart disease equals, even surpasses, men's risk. One possible contributing explanation for the change in risk is that sex hormones affect the sympathetic nervous system, which controls constriction of blood vessels and participates in the fight or flight response.
Pharmacyclics, Inc. announced today that the enrollment target of 350 patients for its Phase III study using ibrutinib monotherapy versus ofatumumab in patients with relapsed or refractory chronic lymphocytic leukemia / small lymphocytic lymphoma, (RESONATE) was achieved on April 3, 2013.
"India is falling behind other countries in meeting international commitments to improve obstetric care because it does not adequately monitor deaths and injuries in the critical period following childbirth and fix gaps in its health system and programmes," Human Rights Watch said Wednesday, the Hindu reports.
Learning from one's mistakes may be better than practicing to perfection, according to a new study appearing in the October 19 issue of The Journal of Neuroscience.
EyeTechCare SA, which develops non-invasive therapeutic medical devices for the ophthalmology market based on the use of ultrasound, today announces that its EyeOP1 device is to be installed in a number of hospitals in France, namely Lille University Hospital, Grenoble University Hospital and the Quinze-Vingts and Saint-Joseph hospitals in Paris. The first use of this device for the routine treatment of glaucoma patients is slated from July onwards.
› Verified 7 days ago
Charlevoix Area Hospital Critical Access Hospital Location: 14700 Lakeshore Drive, Charlevoix, Michigan 49720 Phone: (231) 547-4024 |